Libtayo Prices, Coupons, Copay Cards & Patient Assistance
Libtayo (cemiplimab) is a member of the anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors) drug class and is commonly used for Basal Cell Carcinoma, Non Small Cell Lung Cancer, and Squamous Cell Carcinoma.
Libtayo prices
Intravenous Solution
rwlc 350 mg/7 mL Libtayo intravenous solution from $11,672.61 for 7 milliliters
| Quantity | Per unit | Price |
|---|---|---|
| 7 milliliters | $1,667.52 | $11,672.61 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Get your FREE Drugs.com Discount Card
Save up to 80% off the cost of prescription drugs and OTC medicines valid at over 65,000 pharmacies.
This is a drug discount program, not an insurance plan.
Libtayo Coupons, Copay Cards and Rebates
Libtayo offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Libtayo Surround Commercial Copay Program
Eligible commercially insured patients may pay $0 for copays, coinsurance and deductibles with a maximum savings of $25,000 per year.
- Applies to:
- Libtayo
- Number of uses:
- per prescription per year
Form more information phone: 877-542-8296 or Visit website
Patient Assistance & Copay Programs for Libtayo
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Libtayo (cemiplimab-rwlc) Injection; IV
More information please phone: 866-316-7263 Visit website
Provider: Libtayo Surround Program
Eligibility requirements:- Must be uninsured or underinsured
- At or below 500% of FPL
- Medically Necessary as determined by a Doctor
- Must be residing in the US or US territory
- This program also provides co-pay and reimbursement assistance regardless of income.
- Libtayo (cemiplimab-rwlc) Injection; IV
More information please phone: 877-542-8296 Visit website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Rybrevant
Rybrevant is used to treat advanced non-small cell lung cancer (NSCLC) in adults that has certain ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Erbitux
Erbitux (cetuximab) is used to treat cancers of the colon and rectum. Learn about side effects ...
Blenoxane
Blenoxane is used for hodgkin's lymphoma, non-hodgkin's lymphoma, squamous cell carcinoma ...
Unloxcyt
Unloxcyt (cosibelimab-ipdl) is an anti-PD-1 treatment for metastatic or advanced cutaneous squamous ...
Bleomycin
Bleomycin is used for hodgkin's lymphoma, malignant pleural effusion, non-hodgkin's lymphoma ...
More about Libtayo (cemiplimab)
- Check interactions
- Compare alternatives
- Reviews (9)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español